BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33497488)

  • 1. The Parkinson's Disease DNA Variant Browser.
    Kim JJ; Makarious MB; Bandres-Ciga S; Gibbs JR; Ding J; Hernandez DG; Brooks J; Grenn FP; Iwaki H; Singleton AB; Nalls MA; Blauwendraat C;
    Mov Disord; 2021 May; 36(5):1250-1258. PubMed ID: 33497488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Parkinson's Disease Genome-Wide Association Study Locus Browser.
    Grenn FP; Kim JJ; Makarious MB; Iwaki H; Illarionova A; Brolin K; Kluss JH; Schumacher-Schuh AF; Leonard H; Faghri F; Billingsley K; Krohn L; Hall A; Diez-Fairen M; Periñán MT; Foo JN; Sandor C; Webber C; Fiske BK; Gibbs JR; Nalls MA; Singleton AB; Bandres-Ciga S; Reed X; Blauwendraat C;
    Mov Disord; 2020 Nov; 35(11):2056-2067. PubMed ID: 32864809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease.
    Daida K; Funayama M; Billingsley KJ; Malik L; Miano-Burkhardt A; Leonard HL; Makarious MB; Iwaki H; Ding J; Gibbs JR; Ishiguro M; Yoshino H; Ogaki K; Oyama G; Nishioka K; Nonaka R; Akamatsu W; Blauwendraat C; Hattori N
    Mov Disord; 2023 Dec; 38(12):2249-2257. PubMed ID: 37926948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.
    Iwaki H; Leonard HL; Makarious MB; Bookman M; Landin B; Vismer D; Casey B; Gibbs JR; Hernandez DG; Blauwendraat C; Vitale D; Song Y; Kumar D; Dalgard CL; Sadeghi M; Dong X; Misquitta L; Scholz SW; Scherzer CR; Nalls MA; Biswas S; Singleton AB; ; ;
    Mov Disord; 2021 Aug; 36(8):1795-1804. PubMed ID: 33960523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of GBA1 Variants in Parkinson's Disease: The GBA1-PD Browser.
    Parlar SC; Grenn FP; Kim JJ; Baluwendraat C; Gan-Or Z
    Mov Disord; 2023 Mar; 38(3):489-495. PubMed ID: 36598340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TWNK in Parkinson's Disease: A Movement Disorder and Mitochondrial Disease Center Perspective Study.
    Percetti M; Franco G; Monfrini E; Caporali L; Minardi R; La Morgia C; Valentino ML; Liguori R; Palmieri I; Ottaviani D; Vizziello M; Ronchi D; Di Berardino F; Cocco A; Macao B; Falkenberg M; Comi GP; Albanese A; Giometto B; Valente EM; Carelli V; Di Fonzo A
    Mov Disord; 2022 Sep; 37(9):1938-1943. PubMed ID: 35792653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and genetic study of early-onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next-generation sequencing.
    Lin CH; Chen PL; Tai CH; Lin HI; Chen CS; Chen ML; Wu RM
    Mov Disord; 2019 Apr; 34(4):506-515. PubMed ID: 30788857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of the causative genes for hereditary parkinsonism in the midbrain in Parkinson's disease.
    Kim YJ; Jeon J; Shin J; Kim NY; Hong JH; Oh JM; Hong S; Kim YJ; Kim YE; Kang SY; Ma HI; Lee U; Yoon J
    Mov Disord; 2017 Aug; 32(8):1211-1220. PubMed ID: 28548297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings.
    Skrahina V; Gaber H; Vollstedt EJ; Förster TM; Usnich T; Curado F; Brüggemann N; Paul J; Bogdanovic X; Zülbahar S; Olmedillas M; Skobalj S; Ameziane N; Bauer P; Csoti I; Koleva-Alazeh N; Grittner U; Westenberger A; Kasten M; Beetz C; Klein C; Rolfs A;
    Mov Disord; 2021 Apr; 36(4):1005-1010. PubMed ID: 33314351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
    den Heijer JM; Cullen VC; Quadri M; Schmitz A; Hilt DC; Lansbury P; Berendse HW; van de Berg WDJ; de Bie RMA; Boertien JM; Boon AJW; Contarino MF; van Hilten JJ; Hoff JI; van Mierlo T; Munts AG; van der Plas AA; Ponsen MM; Baas F; Majoor-Krakauer D; Bonifati V; van Laar T; Groeneveld GJ
    Mov Disord; 2020 Sep; 35(9):1667-1674. PubMed ID: 32618053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study.
    Di Fonzo A; Percetti M; Monfrini E; Palmieri I; Albanese A; Avenali M; Bartoletti-Stella A; Blandini F; Brescia G; Calandra-Buonaura G; Campopiano R; Capellari S; Colangelo I; Comi GP; Cuconato G; Ferese R; Galandra C; Gambardella S; Garavaglia B; Gaudio A; Giardina E; Invernizzi F; Mandich P; Mineri R; Panteghini C; Reale C; Trevisan L; Zampatti S; Cortelli P; Valente EM;
    Mov Disord; 2023 Dec; 38(12):2241-2248. PubMed ID: 37750340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical heterogeneity of LRRK2 p.I2012T mutation.
    Fan TS; Wu RM; Chen PL; Chen TF; Li HY; Lin YH; Chen CY; Chen ML; Tai CH; Lin HI; Lin CH
    Parkinsonism Relat Disord; 2016 Dec; 33():36-43. PubMed ID: 27628070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries.
    Kruse C; Lipinski A; Verheyen M; Balzer-Geldsetzer M; Wittenberg M; Lorenzl S; Richinger C; Schmotz C; Tönges L; Woitalla D; Klebe S; Bloem BR; Hommel A; Meissner WG; Laurens B; Boraud T; Foubert-Samier A; Vergnet S; Tison F; Costa N; Odin P; Rosqvist K; Norlin JM; Hjalte F; Schrag A; Dodel R
    Mov Disord; 2024 Mar; 39(3):571-584. PubMed ID: 38425158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients.
    Spataro N; Roca-Umbert A; Cervera-Carles L; Vallès M; Anglada R; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Kulisevsky J; Casals F; Clarimón J; Bosch E
    Mov Disord; 2017 Jan; 32(1):165-169. PubMed ID: 28124432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease.
    Mahlknecht P; Pechlaner R; Boesveldt S; Volc D; Pinter B; Reiter E; Müller C; Krismer F; Berendse HW; van Hilten JJ; Wuschitz A; Schimetta W; Högl B; Djamshidian A; Nocker M; Göbel G; Gasperi A; Kiechl S; Willeit J; Poewe W; Seppi K
    Mov Disord; 2016 Sep; 31(9):1408-13. PubMed ID: 27159493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic landscape of Parkinson's disease.
    Lunati A; Lesage S; Brice A
    Rev Neurol (Paris); 2018 Nov; 174(9):628-643. PubMed ID: 30245141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMEM230: How does it fit in the etiology and pathogenesis of Parkinson's disease?
    Mandemakers W; Quadri M; Stamelou M; Bonifati V
    Mov Disord; 2017 Aug; 32(8):1159-1162. PubMed ID: 28568905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism.
    Dekker MC; Giesbergen PC; Njajou OT; van Swieten JC; Hofman A; Breteler MM; van Duijn CM
    Neurosci Lett; 2003 Sep; 348(2):117-9. PubMed ID: 12902032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.